SWANWOOD PARTNERSHIP — All Prescriptions & Medications — Page 5
Practice Code: F81732 | WICKFORD, SS12 0AG
Showing results 201-250 of 524
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| RtS 2-2.4 kcal/ml m/sk higher protein,higher energy(0913011) | 75 | 408.4K | £4.5K | +71.4% ▲ |
| Bumetanide | 74 | 5,570 | £673 | -72.8% ▼ |
| 74 | 5,832 | £575 | -43.5% ▼ | |
| Dorzolamide | 73 | 1,040 | £616 | -12.2% ▼ |
| Risedronate sodium | 70 | 800 | £379 | -42.3% ▼ |
| Quinine sulfate | 69 | 3,164 | £514 | -76.2% ▼ |
| Calcium carbonate | 69 | 4,460 | £402 | +4.9% ▲ |
| Cyclizine hydrochloride | 68 | 3,354 | £117 | -57.8% ▼ |
| Brinzolamide and timolol | 68 | 395 | £572 | +79.9% ▲ |
| Travoprost | 66 | 508 | £203 | +40.1% ▲ |
| Paroxetine hydrochloride | 65 | 2,318 | £182 | -65.2% ▼ |
| Insulin detemir | 65 | 362 | £3.0K | -17.0% ▼ |
| Dutasteride | 65 | 3,502 | £198 | +26.6% ▲ |
| Hypromellose | 65 | 810 | £181 | -50.9% ▼ |
| Hyoscine butylbromide | 64 | 4,388 | £303 | -72.5% ▼ |
| Zolmitriptan | 64 | 738 | £2.6K | -1.4% vs avg |
| Baclofen | 64 | 6,390 | £152 | -68.1% ▼ |
| 64 | 200 | £1.8K | +130.0% ▲ | |
| Oxycodone hydrochloride | 63 | 7,549 | £797 | -75.4% ▼ |
| 63 | 825 | £231 | -74.8% ▼ | |
| Zolpidem tartrate | 62 | 2,667 | £114 | -31.2% ▼ |
| 62 | 30.5K | £573 | -76.5% ▼ | |
| 62 | 8,060 | £1.1K | +28.6% ▲ | |
| Fluticasone furoate/vilanterol | 61 | 96 | £2.3K | -60.6% ▼ |
| Bisacodyl | 60 | 3,518 | £186 | -54.2% ▼ |
| Azithromycin | 60 | 1,378 | £374 | -52.7% ▼ |
| Dexamethasone | 59 | 501 | £257 | -1.2% vs avg |
| 59 | 4,370 | £583 | +18.2% ▲ | |
| Tranexamic acid | 58 | 3,169 | £216 | -31.6% ▼ |
| Co-beneldopa (Benserazide/levodopa) | 58 | 7,000 | £397 | -61.6% ▼ |
| Terbinafine hydrochloride | 58 | 1,960 | £903 | -6.2% ▼ |
| Insulin Lispro | 58 | 461 | £3.2K | -24.2% ▼ |
| Mefenamic acid | 58 | 2,599 | £490 | +28.4% ▲ |
| Ursodeoxycholic acid | 57 | 8,804 | £2.4K | -13.9% ▼ |
| 57 | 4,430 | £8.0K | +17.0% ▲ | |
| Chlorphenamine maleate | 56 | 6,238 | £148 | -49.3% ▼ |
| Oxcarbazepine | 56 | 8,760 | £2.0K | +100.3% ▲ |
| Leflunomide | 56 | 1,860 | £110 | +48.0% ▲ |
| Hydrocortisone acetate | 56 | 1,740 | £332 | -15.2% ▼ |
| Orlistat | 55 | 5,292 | £1.3K | -33.3% ▼ |
| Azathioprine | 55 | 4,688 | £1.0K | -49.3% ▼ |
| Risperidone | 54 | 2,048 | £135 | -78.7% ▼ |
| Clotrimazole | 54 | 681 | £546 | -51.1% ▼ |
| Coal tar | 54 | 14.0K | £283 | -25.8% ▼ |
| Ciprofloxain/dexameth | 53 | 265 | £309 | +72.6% ▲ |
| Mometasone furoate | 53 | 2,920 | £320 | -60.4% ▼ |
| 53 | 6,169 | £335 | -75.5% ▼ | |
| Nitrazepam | 52 | 1,372 | £73 | +0.1% vs avg |
| 51 | 771 | £1.7K | +29.6% ▲ | |
| 51 | 2,550 | £173 | -26.9% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.